|
PF-30196 |
FARLAC tabletas recubiertas |
2008-04-04 |
|
Ildong Pharmaceutical Co, Ltd. |
República de Corea
|
Landivar |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-30224 |
FARLAC Polvo para solución oral |
2023-04-08 |
|
Ildong Pharmaceutical Co, Ltd. |
República de Corea
|
Pharland |
Droguería Landívar |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-32033 |
PENTIN Forte Comprimidos |
2014-01-29 |
|
Pharland, S.A. |
República de Corea
|
Droguería Landívar |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-53224 |
GLUVIMAX 1000 mg Tabletas recubiertas |
2021-08-30 |
|
World Medicine Ilac San. ve Tic. A.S. |
Turquía
|
Grüner Medika |
Diprohim |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-53226 |
GLUVIMAX 850 mg Tabletas recubiertas |
2021-08-30 |
|
World Medicine Ilac San. ve Tic. A.S. |
Turquía
|
Avances Médicos |
Grüner Medika |
Diprohim |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RMG-HN-M-0124-0060 |
SYNAPSIS Solución estéril |
2029-01-19 |
|
IMEDICAL, S.A. De C.V. |
Honduras
|
Pharevsa |
Droguería Italiana |
Servicio De Comercio Internacional |
Farbiox |
|
Herdez Bodega Central |
Droguería Triez |
Droguería Triez |
Centro Distribuidor, Sociedad Anónima |
Centro Distribuidor, Sociedad Anónima |
|
|
|
|
|
|
|
|
|
|
|
PF-25835 |
AMOXICILINA Eron 500 mg capsulas |
2006-02-27 |
|
Eron, S.A. |
Cuba
|
San Marcos |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-25847 |
ACETAMINOFEN Eron 500 mg tabletas |
2006-03-16 |
|
Carlos Fernando Fernandez Garcia |
Cuba
|
San Marcos |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-60229 |
AZITROMICINA Vijayasudha 500 mg Polvo para uso parenteral |
2026-10-18 |
|
Vijayasudha Pharmaceuticals Pvt.Ltd. |
India
|
Dispromed |
VMG Healthcare Products |
Wensur |
Arael de Centro América |
Droguería Colón |
LCJ |
La Botica |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-50545 |
SITAGIL 100 Comprimidos Recubiertos simples |
2024-08-08 |
|
Incepta Pharmaceuticals, Ltd. |
Bangladesh
|
Comercializadora De Productos Farmacológicos |
Imcorsa |
Medicamentos Avanzados, Sociedad Anónima |
Soluciones Médicas De C.A. |
Resevsa |
Bawell Pharma |
|
|
|
|
|
|
|
|
|
|
|
|
|
|